Growth Opportunities in Protein Expression Market Protein Expression

Protein Expression Market worth 2,850.5 Million USD by 2022 According to the new market research report "Protein Expression Market by Type (E. Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus, Cell-free), Products (Competent Cells, Reagents, Instruments, Services), Application (Therapeutic, Research, Industrial) & End User - Global Forecast to 2022 ", published by MarketsandMarkets™, the protein expression market is expected to reach USD 2,850.5 Million by 2022 from USD 1,654.0 Million in 2017, at a CAGR of 11.5% during the forecast period. Don’t miss out on business opportunities in Protein Expression Market The prevalence of chronic diseases, increasing research activities on recombinant-based proteins, and growing life sciences & biopharmaceutical industries are the major factors driving the growth of this market. By systems type, the prokaryotic expression systems segment is expected to dominate the market in 2017 On the basis of systems type, the protein expression market is segmented into prokaryotic expression systems; insect cell expression systems; mammalian cell expression systems; yeast expression systems; cell-free expression systems; and algal-based expression systems. The prokaryotic expression systems segment has been sub-segmented into Escherichia coli (E. coli) systems and other systems. The E. coli systems segment accounted for the largest share of this market segment. This growth can be attributed to the increasing use of E. coli systems for the production of commercial proteins. Browse and in-depth TOC on "Protein Expression Market" 127 - Tables 38 - Figures 173 - Pages Download PDF Brochure: By product, the reagents segment is expected to hold the largest share of the market in 2017 The protein expression market is segmented into competent cells, expression vectors, instruments, reagents, and services on the basis of products. The reagents segment holds the largest share and also expected to grow at the highest growth rate during the forecast period. This positive growth trend is primarily attributed to increasing research activities and large- scale production of antibodies and vaccines that require kits and reagents.